NEUROCRINE BIOSCIENCES INC (NBIX) /
The revenue of NEUROCRINE BIOSCIENCES INC over the past 10 years
Chart NEUROCRINE BIOSCIENCES INC: revenue, fiscal 2016–2025 Open the chart →NEUROCRINE BIOSCIENCES INC reported revenue of $2.86B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $15M — up 18970% over 9 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2017: up 978%, from $15M to $161.63M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $2.86B |
| 2024ended Dec 31, 2024 | $2.36B |
| 2023ended Dec 31, 2023 | $1.89B |
| 2022ended Dec 31, 2022 | $1.49B |
| 2021ended Dec 31, 2021 | $1.13B |
| 2020ended Dec 31, 2020 | $1.05B |
| 2019ended Dec 31, 2019 | $788.1M |
| 2018ended Dec 31, 2018 | $451.2M |
| 2017ended Dec 31, 2017 | $161.63M |
| 2016ended Dec 31, 2016 | $15M |
Fiscal years as NEUROCRINE BIOSCIENCES INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NEUROCRINE BIOSCIENCES INC
- The profitability of NEUROCRINE BIOSCIENCES INC
- The cash flow of NEUROCRINE BIOSCIENCES INC
- The debt of NEUROCRINE BIOSCIENCES INC
- All of NEUROCRINE BIOSCIENCES INC's financials, charted
Companies of a similar size
- JAZZJazz Pharmaceuticals plc
- PFGCPerformance Food Group Company
- RBCRBC BEARINGS INCORPORATED
- WWayfair Inc.
- SWKSTANLEY BLACK & DECKER, INC.
Not investment advice. This page shows what NEUROCRINE BIOSCIENCES INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.